University of Miami researchers said nonalcoholic steatohepatitis, or NASH, patients are good candidates for liver transplants with survival rates similar to those for other causes of cirrhosis. NASH patients who receive new livers are, however, at increased risk of complications from diseases related to metabolic syndrome, study data showed.

Related Summaries